Irvine-based Inari Medical Inc. has entered into an agreement to be acquired for $4.9 billion by medical technology company ...
Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...
Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...
Hosted on MSN1d
BTIG Downgrades Inari Medical (NARI)Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Hosted on MSN2d
William Blair Downgrades Inari Medical (NARI)Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...
Zacks.com on MSN6d
Reasons to Retain Inari Medical Stock in Your Portfolio for NowNARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.
Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...
To facilitate commercialization of the ClotTriever system in Japan, Inari has entered into a distribution agreement with Medikit Co., Ltd., a market leading vascular medical device manufacturer ...
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...
In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Inari Medical (NARI – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback